- In April 2022, Nanox received approval from the U.S. FDA for its HealthOST device, an AI-powered software designed to monitor vertebral compression fractures and detect osteoporosis by assessing poor bone density. This advancement in diagnostic technology positions Nanox to strengthen its competitive edge in the market, offering innovative solutions for early osteoporosis detection and expanding its portfolio of medical devices
- In August 2021, IZI Medical Products launched the Vertefix HV cement, an advanced device for kyphoplasty and vertebroplasty surgeries that enables real-time flow visualization during cement injection. This innovation enhances the precision and effectiveness of kyphoplasty procedures, allowing IZI Medical Products to broaden its product offerings and capture a larger share of the growing kyphoplasty market
- In May 2021, Medtronic plc had announced the U.S. launch of New Directional Cannula for Balloon Kyphoplasty. According to a study, hospitals in the United States reported a 35 percent drop in operating room volume from March to July 2020. During the COVID period, however, the market for robotic spinal surgery increased. Furthermore, the demand for spinal surgery medical instruments and equipment has decreased dramatically
